Company / Cash per Share
Kura Oncology, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.91
FY2025
5-year range
$0.51 / $3.02
FY2021-FY2025
Trend
-36.9%
vs FY2024
Sector context
#110 of 205
Health Care
What the data says
At $1.91, Kura Oncology, Inc.'s cash per share ranks #110 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.46 in FY2018 to $6.13 in FY2020.
Based on SEC 10-K filings.
1.91 in FY2025 with a 5-year CAGR of -20.8%.
Improved from $0.51 to $1.91 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +35.1%
- 5-Year CAGR
- -20.8%
- 10-Year CAGR
- -
Sector benchmark
#110 of 205 in Health CareTop 54% of 205This company $1.91 Sector average $72.93
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 36.9% year-over-year.
- Ranks #110 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.91 | -36.9% |
| FY2024 | $3.02 | +492.4% |
| FY2023 | $0.51 | -34.1% |
| FY2022 | $0.77 | -43.4% |
| FY2021 | $1.37 | -77.7% |
| FY2020 | $6.13 | +884.2% |
| FY2019 | $0.62 | +36.0% |
| FY2018 | $0.46 | -6.9% |
| FY2017 | $0.49 | -5.4% |
| FY2016 | $0.52 | -66.6% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026